Outcomes of acute liver injury (ALI) in adults due to Wilson Disease: Is survival without transplant possible?
Wilson Disease (WD) is a rare cause of acute liver failure (ALF) thought to have a uniformly fatal outcome without liver transplantation (LT). Previous studies proposed diagnostic and prognostic criteria for WD-ALF. It is not known whether these apply to WD patients presenting as severe acute liver injury (WD-ALI) without encephalopathy. From 2008-2018, 822 subjects with ALI in the US Acute Liver Failure Study Group Registry (ALFSG) were enrolled and prospectively followed. The diagnosis of WD-ALI was confirmed in eight. Serum biochemical diagnostic ratios predicting WD-ALF (ALP: bilirubin and AST:ALT) were determined in these patients. Predictors of prognosis for WD-ALI were evaluated. Five of 8 ALI-WD patients received a LT. Ratios of both ALP: bilirubin of <4 and AST:ALT of >2.2 on study admission were met in 4 LT patients. All LT patients were female. Admission MELD scores were generally higher in LT patients. All transplanted patients had an initial revised WD score of >11 (>10 predicting poor outcome without LT in WD-ALF) while in non-LT patients, 2 had scores of 9 and 1 a score of 13. Three LT patients were started on chelation therapy and 2 on plasmapheresis and 1 on MARS therapy. All non-LT patients were treated with chelation. At 21 days all patients were alive and discharged from hospital. Some patients with ALI due to WD may survive without LT. Revised WD Index scores >10 predict poor outcome in most patients with WD-ALI, as they do for WD-ALF, and correlate positively with the ALI model in this cohort. Biochemical ratios for WD diagnosis appear more applicable to ALF compared to WD-ALI.